Tomas Kaplan is a seasoned professional in the pharmaceutical industry with extensive experience in commercial strategy and marketing. Currently serving as Director of Commercial Strategy & Innovation at Pfizer since January 2020, Tomas supports global commercialization efforts for BRAF mutant colorectal cancer and non-small cell lung cancer. Prior to this role, Tomas was with Array BioPharma Inc. from 2014 to 2020, holding various leadership positions, including Director of Marketing and Associate Director of Product Management, focusing on melanoma treatments. Tomas's early career included roles as Senior Outsourcing Specialist and Investment Analyst, along with founding VisitMobile, Inc. and contributing to the development of innovative mobile marketing solutions. Tomas holds an MBA in International Business from the University of Colorado Denver and dual BS degrees in Chemistry from Mercer University.
This person is not in any teams
This person is not in any offices